Literature DB >> 12678354

A ten- to 15-year follow-up of the cementless spotorno stem.

P R Aldinger1, S J Breusch, M Lukoschek, H Mau, V Ewerbeck, M Thomsen.   

Abstract

We followed the first 354 consecutive implantations of a cementless, double-tapered straight femoral stem in 326 patients. Follow-up was at a mean of 12 years (10 to 15). The mean age of the patients was 57 years (13 to 81). At follow-up, 56 patients (59 hips) had died, and eight (eight hips) had been lost to follow-up. Twenty-five hips underwent femoral revision, eight for infection, three for periprosthetic fracture and 14 for aseptic loosening. The overall survival was 92% at 12 years (95% CI 88 to 95). Survival with femoral revision for aseptic loosening as an endpoint was 95% (95% CI 92 to 98). The median Harris hip score at follow-up was 84 points (23 to 100). Radiolucent lines (< 2 mm) in Gruen zones 1 and 7 were present in 38 (16%) and 34 hips (14%), respectively. Radiolucencies in zones 2 to 6 were found in five hips (2%). The results for mid- to long-term survival with this femoral component are encouraging and compare with those achieved in primary cemented total hip arthroplasty. The high rate of loosening of the cup and the high rate of pain are, however, a source of concern.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678354     DOI: 10.1302/0301-620x.85b2.13216

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  38 in total

1.  [Proposal for the classification of the periprosthetic membrane from loosened hip and knee endoprostheses].

Authors:  L Morawietz; Th Gehrke; R-A Classen; B Barden; M Otto; T Hansen; Th Aigner; P Stiehl; J Neidel; J H Schröder; L Frommelt; Th Schubert; C Meyer-Scholten; A König; Ph Ströbel; Ch P Rader; S Kirschner; F Lintner; W Rüther; A Skwara; I Bos; J Kriegsmann; V Krenn
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

2.  [Total hip replacement--GPs' views in Germany. A questionnaire-based study].

Authors:  K Schröder; M Zimmermann-Stenzel; D Parsch
Journal:  Orthopade       Date:  2007-10       Impact factor: 1.087

3.  High incidence of intraoperative calcar fractures with the cementless CLS Spotorno stem.

Authors:  Carla Timmer; Davey M J M Gerhardt; Enrico de Visser; Marinus de Kleuver; Job L C van Susante
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-05-07

4.  Fifteen- to 20-year results of uncemented tapered fully porous-coated cobalt-chrome stems.

Authors:  Taek Rim Yoon; Sung-Man Rowe; Myung-Sun Kim; Sang-Gwon Cho; Jong-Keun Seon
Journal:  Int Orthop       Date:  2007-02-24       Impact factor: 3.075

Review 5.  [Histopathologic diagnostics in endoprosthetics: periprosthetic neosynovialitis, hypersensitivity reaction, and arthrofibrosis].

Authors:  V Krenn; M Otto; L Morawietz; T Hopf; M Jakobs; W Klauser; B Schwantes; T Gehrke
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

6.  Survival of the cementless Spotorno stem in the second decade.

Authors:  Peter R Aldinger; Alexander W Jung; Steffen J Breusch; Volker Ewerbeck; Dominik Parsch
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

7.  Second-generation extensively porous-coated THA stems at minimum 10-year followup.

Authors:  David W Hennessy; John J Callaghan; Steve S Liu
Journal:  Clin Orthop Relat Res       Date:  2009-04-14       Impact factor: 4.176

8.  Long-term results and bone remodeling after THA with a short, metaphyseal-fitting anatomic cementless stem.

Authors:  Young-Hoo Kim; Jang-Won Park; Jun-Shik Kim; Jun-Seok Kang
Journal:  Clin Orthop Relat Res       Date:  2013-10-26       Impact factor: 4.176

9.  [Joint endoprosthesis pathology. Histopathological diagnostics and classification].

Authors:  V Krenn; L Morawietz; M Jakobs; H Kienapfel; R Ascherl; L Bause; H Kuhn; G Matziolis; M Skutek; T Gehrke
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

10.  A stature-specific concept for uncemented, primary total hip arthroplasty.

Authors:  Georg W Omlor; Hannah Ullrich; Knut Krahmer; Alexander Jung; Günther Aldinger; Peter Aldinger
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.